137 related articles for article (PubMed ID: 8537281)
1. A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster.
Moss PJ; Wood MJ; Crooks RJ; Gallagher J; McKendrick MW
J Antimicrob Chemother; 1995 Jul; 36(1):271-3. PubMed ID: 8537281
[No Abstract] [Full Text] [Related]
2. Severe acyclovir-induced encephalopathy in an elderly patient with herpes zoster.
Nakajima K; Momo K; Nimura S; Kaizaki-Mitsumoto A; Kanazawa N; Inaba T; Saito T; Wada Y; Honda H; Numazawa S; Sasaki T
Eur J Clin Pharmacol; 2022 Mar; 78(3):527-529. PubMed ID: 34714374
[No Abstract] [Full Text] [Related]
3. Acyclovir-induced colitis.
Wardle TD; Finnerty JP; Swale V; Beer T
Aliment Pharmacol Ther; 1997 Apr; 11(2):415-7. PubMed ID: 9146784
[TBL] [Abstract][Full Text] [Related]
4. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].
Helldén A; Bergman U; Dwyer R; Medin C; Molanaei H; Ståhle L; Thylén P; Odar-Cederlöf I
Lakartidningen; 2007 Jun 13-26; 104(24-25):1916-20. PubMed ID: 17674672
[No Abstract] [Full Text] [Related]
5. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics.
Acosta EP; Balfour HH
Antimicrob Agents Chemother; 2001 Oct; 45(10):2771-4. PubMed ID: 11557467
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group.
Söltz-Szöts J; Tyring S; Andersen PL; Lucht RF; McKendrick MW; Diaz Perez JL; Shukla S; Fiddian AP
J Antimicrob Chemother; 1998 May; 41(5):549-56. PubMed ID: 9630408
[TBL] [Abstract][Full Text] [Related]
7. Neurological deterioration in the treatment of Herpes zoster: encephalitis or neurotoxic effect of acyclovir?
De Cauwer H; Maes J; Viaene M; Janssen L; Belmans L
Acta Neurol Belg; 2017 Mar; 117(1):395-397. PubMed ID: 27418364
[No Abstract] [Full Text] [Related]
8. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
9. More about acyclovir neurotoxicity in patients on haemodialysis.
Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
[No Abstract] [Full Text] [Related]
10. Open study of 2-amino-9-(hydroxyethoxymethyl)-9H-purine (desciclovir) in the treatment of herpes zoster.
Peterslund NA; Esmann V; Geil JP; Petersen CM; Mogensen CE
J Antimicrob Chemother; 1987 Nov; 20(5):743-51. PubMed ID: 3429375
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
[TBL] [Abstract][Full Text] [Related]
12. [Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir].
Braun JS; Apel I; Schäffer S; Schumacher M; Berger M
Nervenarzt; 1998 Nov; 69(11):1015-8. PubMed ID: 9859124
[TBL] [Abstract][Full Text] [Related]
13. Aciclovir induced posterior leucoencephalopathy.
Mahad DJ; Helldén A; Jarvis J; Mitra D; Gholkar A; Chinnery PF
J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1308-9. PubMed ID: 16107379
[No Abstract] [Full Text] [Related]
14. Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudin.
Aksoy B; Altaykan-Hapa A; Cengiz A; Mete Aksoy H; Atakan N
Eur J Dermatol; 2010; 20(2):247-8. PubMed ID: 20103497
[No Abstract] [Full Text] [Related]
15. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
[TBL] [Abstract][Full Text] [Related]
16. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
17. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster.
Kurokawa I; Murakawa K; Kumano K
Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.
Yoshimura T; Kawasaki T; Shirota A; Saeki M; Okada Y; Okada H
Intern Med; 2018 Nov; 57(21):3213-3216. PubMed ID: 29877263
[TBL] [Abstract][Full Text] [Related]
19. Coma secondary to aciclovir neurotoxicity.
Loughrey J; Coleman P; Donohue J; Marsh B
Ir J Med Sci; 2001; 170(1):69-70. PubMed ID: 11440418
[No Abstract] [Full Text] [Related]
20. Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairment.
Brady M; Main J
Clin Med (Lond); 2009 Dec; 9(6):630. PubMed ID: 20095318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
